12月26日，唯特偶发布公告，宣布与深圳市华睿欣能投资控股集团有限公司（以下简称"华睿欣能"）签署《战略合作协议》，双方将围绕新材料研发、应 用场景拓展、标准制定等方面开展全方位合作，共建联合实验室，携手开拓电力及新能源相关市场。 在具体合作分工上，华睿欣能将负责整合渠道与市场资源、主导合资公司经营管理、推广合作产品、协调客户及政府资源、牵头标准制定与专利申报等； 唯特偶将提供核心技术与生产工艺支持、配合产品共同开发与性能优化、提供技术培训与售后维护服务等。双方互为优先合作方，将提供优惠合作政策与 条款，具体合作细节将通过专项协议进一步明确。 协议有效期为生效之日起五年，期满前双方未书面提出终止则自动续期五年。 公告显示，本次战略合作秉持"资源互补、协同赋能、合作共赢"核心原则与"灭初始之火，守万家灯火，愿天下无灾"共同愿景。唯特偶将发挥其在全氟己 酮微胶囊等新型灭火产品、弹性装甲涂料、阻燃材料、微电子装联材料等领域的研发、规模化生产及供应链整合优势；华睿欣能则依托其在深圳电力领域 安全防护技术、应用场景落地及市场资源整合的核心实力，双方协同提升产品市场竞争力，共同开拓电力材料、电力配套设施等相关应用场景。 ...

唯特偶（301319）12月26日晚公告，公司与深圳市华睿欣能投资控股集团有限公司(以下简称"华睿欣 能")签订了《战略合作协议》，希望通过建立战略合作关系，聚焦产品协同开发、应用场景拓展，共建 联合实验室，携手推动地区及行业标准迭代升级，优先在深圳区域的电力行业相关领域推广使用，后续 进行全国推广。 唯特偶将负责提供合作产品的核心技术、生产工艺支持，保障产品质量符合应用场景要求；主导或配合 合资公司开展产品共同开发工作，根据应用场景需求优化产品性能；提供产品相关的技术培训、售后维 护等服务，协助甲方及客户正确使用产品；配合合资公司开展标准制定、专利申报等工作，提供相关技 术资料支持。 根据双方签署的合作协议书，双方将充分发挥唯特偶在全氟己酮微胶囊等新型灭火产品、弹性装甲涂 料、阻燃材料、微电子装联材料等新材料研发、规模化生产、供应链整合等方面的优势，以及华睿欣能 在深圳电力领域安全防护技术、应用场景落地、市场资源整合等方面的核心实力，实现优势互补，提高 唯特偶产品在电力及相关领域市场竞争力，共同开拓电力材料、电力配套设施、电力衍生等相关应用场 景。 唯特偶表示，本协议通过建立战略合作关系，有利于充分发挥唯特 ...

人民财讯12月26日电，唯特偶（301319）12月26日公告，近日，公司与深圳市华睿欣能投资控股集团有 限公司(简称"华睿欣能")签订《战略合作协议》，希望通过建立战略合作关系，充分发挥唯特偶在全氟 己酮微胶囊等新型灭火产品、弹性装甲涂料、阻燃材料、微电子装联材料等新材料研发、规模化生产、 供应链整合等方面的优势，聚焦产品协同开发、应用场景拓展，共建联合实验室，携手推动地区及行业 标准迭代升级，提升双方核心竞争力与行业影响力。 ...

格隆汇12月26日丨唯特偶(301319.SZ)公布，公司与深圳市华睿欣能投资控股集团有限公司（简称"华睿 欣能"）签订了《战略合作协议》，希望通过建立战略合作关系，充分发挥唯特偶在全氟己酮微胶囊等 新型灭火产品、弹性装甲涂料、阻燃材料、微电子装联材料等新材料研发、规模化生产、供应链整合等 方面的优势，秉持"资源互补、协同赋能、合作共赢"的核心原则，秉持"灭初始之火，守万家灯火，愿 天下无灾" 的共同愿景，聚焦产品协同开发、应用场景拓展，共建联合实验室，携手推动地区及行业标 准迭代升级，提升双方核心竞争力与行业影响力，达成互利共赢的战略目标。 ...

每经头条（nbdtoutiao）——对话马斯克脑机接口"一号受试者"：大脑植入芯片23个月，我正重新夺回 人生的独立 2024年1至12月份，唯特偶的营业收入构成为：计算机和通信和其他电子设备制造业占比100.0%。 截至发稿，唯特偶市值为65亿元。 每经AI快讯，唯特偶（SZ 301319，收盘价：52.23元）12月26日晚间发布公告称，近日，公司与华睿欣 能签订了《战略合作协议》，希望通过建立战略合作关系，充分发挥唯特偶在全氟己酮微胶囊等新型灭 火产品、弹性装甲涂料、阻燃材料、微电子装联材料等新材料研发、规模化生产、供应链整合等方面的 优势，秉持"资源互补、协同赋能、合作共赢"的核心原则，秉持"灭初始之火，守万家灯火，愿天下无 灾"的共同愿景，聚焦产品协同开发、应用场景拓展，共建联合实验室，携手推动地区及行业标准迭代 升级，提升双方核心竞争力与行业影响力，达成互利共赢的战略目标。 （记者 曾健辉） ...

唯特偶公告，公司与华睿欣能签订了《战略合作协议》，旨在建立战略合作关系，发挥唯特偶在全氟己 酮微胶囊等新型灭火产品、弹性装甲涂料、阻燃材料、微电子装联材料等新材料研发、规模化生产、供 应链整合等方面的优势，共同开发产品和应用场景，成立联合实验室，推动地区标准和行业标准制定， 优先在深圳区域的电力行业相关领域推广使用，后续进行全国推广。 ...

（编辑 王雪儿） 证券日报网讯 会通股份11月20日在互动平台回答投资者提问时表示，公司阻燃材料应用领域广泛，公 司围绕目前常见的通用塑料以及工程塑料均有对应的不同等级的阻燃方案，在家电、汽车、消费电子、 光伏等众多行业中均有应用。其中，围绕着家电领域的涉电部件如电控盒等应用场景推出完善的阻燃材 料解决方案；在汽车电子电器系统中，针对新能源车辆线束、连接系统、"三电"系统及充电相关部件， 公司推出低析出、低模垢阻燃尼龙材料、防火高CTI尼龙材料等材料解决方案，聚焦电器安全与可靠性 提升；在连接器领域，公司研发出了耐寒红磷阻燃增强尼龙材料，成功应用于光伏连接器，新能源连接 器等关键部件。 ...

Core Insights - Technological innovation is deemed essential for the vitality of enterprises, particularly in the materials sector, where stagnation leads to regression [1][2] - The company, Guangdong Jushi Chemical Co., Ltd., focuses on flame retardant and polymer materials, with plans to expand into new materials required for emerging sectors such as renewable energy, low-altitude economy, photovoltaics, and robotics [1][2] Company Development - Jushi Chemical has evolved into a publicly listed company on the Sci-Tech Innovation Board, with a core focus on flame retardant materials [2] - The company has significantly increased its R&D investment, with R&D expenses reaching 128 million yuan in 2023, accounting for 3.5% of revenue, and projected to rise to 139 million yuan in 2024 [2] Innovation and Patents - The company has achieved substantial breakthroughs in core technologies, filling domestic gaps, including the successful application of high-performance fireproof coatings in oil drilling platforms, disrupting the long-standing international monopoly [2] - As of June this year, the company has obtained a total of 425 authorized patents, including 234 invention and overseas patents [2] Future Directions - The company aims to maintain its focus on flame retardant and polymer materials while exploring biodegradable, low-carbon, and circular economy directions [2] - Plans include enhancing market competitiveness and expanding both domestic and international market presence, promoting "Chinese flame retardant technology" globally [2]

Group 1: Japanese Chemical Industry Investment in China - Japanese chemical companies have significantly increased their investments in China's chemical industry, with over 8 investments totaling more than 30 billion RMB in the past year [4][5] - Factors contributing to this investment surge include the structural adjustments of both countries' industries, long-term development benefits of the Chinese market, and strategic considerations of Japanese companies [4][5] - The rapid development of China's chemical industry, particularly in green technology and new materials, aligns with Japan's strengths, creating complementary opportunities [5] Group 2: Challenges and Strategic Shifts - A survey by the Japan Policy Investment Bank revealed that 42.6% of large Japanese manufacturing firms plan to reduce their operations in China, the highest level recorded [6] - The U.S.-China trade dispute is a primary driver for this strategic shift, with over 40% of firms citing "diversifying supply chain risks" as a key reason for scaling back [6] - Despite these challenges, many Japanese companies remain deeply embedded in China's local supply chains, making withdrawal impractical [6] Group 3: Toyota's Third-Country Supply Chain Strategy - Toyota has adopted a "third-country supply chain" model to mitigate geopolitical risks, exemplified by its partnership with Thailand's Summit Group to produce low-cost auto parts for electric vehicles [7] - This strategy aims to reduce electric vehicle production costs by 30% while leveraging the cost advantages of Southeast Asia and the quality of Chinese components [7] Group 4: Panasonic's Home Technology Business - Panasonic has established its first independent residential equipment company in China, despite the ongoing downturn in the real estate market [8] - The company is poised to capitalize on structural opportunities, as many older homes are undergoing renovations, driven by consumers seeking high-quality living environments [8] - Panasonic's home business is expected to reach a revenue scale of 10 billion RMB, with projections indicating a threefold increase by 2025 [9]

Financial Data and Key Metrics Changes - The company reported second quarter organic sales growth of 0.6% and adjusted EPS growth of 5% to $0.80, slightly ahead of guidance [6][11] - Adjusted EBITDA margin expanded by 30 basis points to 17.2%, driven by favorable mix and productivity initiatives [6][11] - For the first half of the year, organic sales grew about 1%, with expectations for a similar demand environment in the second half [7][11] Business Line Data and Key Metrics Changes - The Color Additives and Inks segment saw adjusted EBITDA grow 4% despite a 2% decline in organic sales, with weaker demand in consumer and transportation markets [16][17] - Specialty Engineered Materials segment grew organic sales by 6%, driven by strong growth in defense and healthcare, with healthcare growing double digits [18][19] - Packaging Materials segment's sales were muted, but EBITDA margins expanded by 100 basis points through cost improvement initiatives [16][17] Market Data and Key Metrics Changes - In the U.S. and Canada, sales increased by 1% year over year, led by healthcare and defense, offsetting weaker demand in other sectors [20] - EMEA sales were slightly down, with robust healthcare and defense sales but muted packaging sales [21] - Latin America grew 6%, marking its sixth consecutive quarter of growth, while Asia delivered 3% organic growth [21] Company Strategy and Development Direction - The company aims to evolve from a specialty formulator to an innovator of material solutions, with a focus on strategic structural changes in R&D to enhance product differentiation [10][12] - The operational playbook is designed to navigate low demand and high uncertainty, targeting approximately $40 million in benefits for 2025 [8][12] - Continued investment in growth vectors and strategic initiatives is prioritized, with a focus on healthcare, defense, and telecommunications as key growth drivers [12][19] Management's Comments on Operating Environment and Future Outlook - Management noted that market trends are not improving, with customers remaining in a wait-and-see mode, particularly in consumer markets [6][7] - The company expects Q3 to mirror Q2, with continued strength in defense and healthcare offsetting consumer weakness [7][22] - There is cautious optimism regarding the second half of the year, with expectations for adjusted EPS of $0.70, representing 8% growth year over year [22][23] Other Important Information - The company has a strong cash position, having paid down $50 million of debt during the quarter, and is on track to reduce total debt by $100 million to $200 million by year-end [12][23] - Patent filings increased by 50% in 2024 compared to 2023, indicating a focus on innovation [13] - The company expects CapEx for the year to be approximately $110 million and free cash flow to range from $190 million to $210 million [23] Q&A Session Summary Question: Is there any pre-buying activity affecting sales? - Management indicated no significant pre-buying activity has been observed, as customers are managing inventory tightly in uncertain demand environments [26][28] Question: What is the outlook for raw material inflation? - The company expects raw material inflation to remain at 1% to 2%, with some fluctuations in specific materials [30][31] Question: What is the outlook for volume in the second half? - Management expects a continuation of trends from the first half, with healthcare, defense, and telecommunications driving growth, while consumer and packaging markets may see slight declines [35][36] Question: How has consumer weakness evolved? - Consumer sales were flat in Q1 but down 8% in Q2, with significant weakness noted in the U.S. and Canada [45][46] Question: What is the impact of planned maintenance on EBITDA? - The planned maintenance impacted EBITDA by approximately $3 million in Q2, but margins are expected to expand in the second half [47][48] Question: Are customers pressuring to absorb tariff costs? - Management acknowledged pressure from customers regarding pricing due to increased tariffs, but they are working to manage costs and maintain pricing [51][52] Question: Can you provide context on the healthcare growth? - Healthcare has shown strong growth, particularly in medical devices and drug delivery, with a long-term positive outlook [61][62] Question: What are the trends in key markets in China? - The color business in China is under pressure due to government policies, but growth is expected in high-performance computing [67][68]